This report investigates the utility of the Pharmaceuticals Benefits Scheme (PBS) and Medicare Benefits Schedule (MBS) claims data in answering key research questions for reporting on the treatment and management of chronic respiratory conditions in Australia. It also includes high level analysis on medications dispensed for the treatment and management of chronic respiratory conditions in 2016–17, and dispensing patterns.